错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Transgelin 2 guards T cell lipid metabolism and antitumour function

  • Sung-Min Hwang,
  • Deepika Awasthi,
  • Jieun Jeong,
  • Tito A. Sandoval,
  • Chang-Suk Chae,
  • Yusibeska Ramos,
  • Chen Tan,
  • Matías Marin Falco,
  • Camilla Salvagno,
  • Alexander Emmanuelli,
  • Ian T. McBain,
  • Bikash Mishra,
  • Lionel B. Ivashkiv,
  • Dmitriy Zamarin,
  • Evelyn Cantillo,
  • Eloise Chapman-Davis,
  • Kevin Holcomb,
  • Diana K. Morales,
  • Xiaoqing Yu,
  • Paulo C. Rodriguez,
  • Jose R. Conejo-Garcia,
  • Martin Kaczocha,
  • Anna Vähärautio,
  • Minkyung Song,
  • Juan R. Cubillos-Ruiz

摘要

Mounting effective immunity against pathogens and tumours relies on the successful metabolic programming of T cells by extracellular fatty acids13. Fatty-acid-binding protein 5 (FABP5) has a key role in this process by coordinating the efficient import and trafficking of lipids that fuel mitochondrial respiration to sustain the bioenergetic requirements of protective CD8+ T cells4,5. However, the mechanisms that govern this immunometabolic axis remain unexplored. Here we report that the cytoskeletal organizer transgelin 2 (TAGLN2) is necessary for optimal fatty acid uptake, mitochondrial respiration and anticancer function in CD8+ T cells. TAGLN2 interacts with FABP5 to facilitate its cell surface localization and function in activated CD8+ T cells. Analyses of ovarian cancer specimens revealed that endoplasmic reticulum (ER) stress responses induced by the tumour microenvironment repress TAGLN2 in infiltrating CD8+ T cells, thereby enforcing their dysfunctional state. Restoring TAGLN2 expression in ER-stressed CD8+ T cells increased their lipid uptake, mitochondrial respiration and cytotoxic capacity. Accordingly, chimeric antigen receptor T cells overexpressing TAGLN2 bypassed the detrimental effects of tumour-induced ER stress and demonstrated therapeutic efficacy in mice with metastatic ovarian cancer. Our study establishes the role of cytoskeletal TAGLN2 in T cell lipid metabolism and highlights the potential to enhance cellular immunotherapy in solid malignancies by preserving the TAGLN2–FABP5 axis.